Objective: Current guidelines recommend high-priority treatment of severe sickle cell disease (SCD) pain with opioids; however, patients with SCD have historically been undertreated. We used mixed methods to assess pediatric residents' perceptions toward opioid use in SCD pain management.
INTRODUCTION
Sickle cell disease (SCD) is a genetic disorder that causes erythrocytes to become rigid and "sickle" shaped, causing episodes of severe pain, termed vaso-occlusive episodes (VOE). 1 VOEs are associated with microvascular occlusion and tissue ischemia, which can cause increased morbidity and mortality. 2 The National Heart, Lung and Blood Institute's (NHLBI) recently published guidelines for SCD Abbreviations: BCHO, UCSF Benioff Children's Hospital Oakland; ED, emergency department; EMR, electronic medical record; NHLBI, National Heart, Lung and Blood Institute; REDCap, Research Electronic Data Capture; SCD, sickle cell disease; SCDIC, Sickle Cell Disease Implementation Consortium; UCSF, University of California San Francisco; VOE, vaso-occlusive episode management recommend immediate and high-priority treatment for patients with SCD presenting with VOE, with opioids recommended as the first-line treatment. 3 Although opioids are a necessity in SCD pain management, challenges in the use of opioids with any patient include respiratory, cognitive, and psychomotor side effects, as well as the potential for misuse. 4 It is well documented that sickle cell pain is often undertreated. [5] [6] [7] Negative provider attitudes toward patients with SCD have been shown to present significant barriers to patients receiving adequate pain management. 7 Studies have shown that some healthcare providers hold false beliefs that patients with SCD are drug-seeking, drug-abusing, or manipulative. 7 There is often a lack of trust on the part of both providers and patients, inadequate knowledge in the medical community about SCD treatment, and an overall inequity in access to adequate SCD care. 5 Furthermore, the current opioid epidemic has heightened the medical community's awareness and fear of prescribing opioids. As a result, physicians today may be more cautious in prescribing opioids, even in the treatment of VOE. 8 Little research has been done into medical residents' attitudes toward patients with SCD. This study is the first, to our knowledge, to specifically evaluate residents' perceptions and attitudes about SCD and pain management.
Our aim was to assess perceived barriers to pain management in SCD, attitudes toward caring for patients with SCD, and whether clinical experience influences these outcomes.
METHODS
This study was conducted as part of a larger initiative funded by NHLBI, the Sickle Cell Disease Implementation Consortium (SCDIC).
The SCDIC was established to use implementation science 9 to address the pervasive and long-standing disparities that youth and adults with SCD face in receiving acute and preventative care. The SCDIC investigators developed a set of survey and qualitative tools to conduct needs assessments of barriers to care at participating sites. We modified the SCDIC instruments to create surveys and interviews that we administered to pediatric residents at UCSF Benioff Children's Hospital Oakland (BCHO).
Participants
Eighty-eight pediatric residents at BCHO, an urban pediatric medical center in California, were eligible to participate. Five of the pediatric residents volunteered for separate individual interviews on pain management in SCD. All study procedures were approved by the BCHO Institutional Review Board.
Instrumentation
We distributed a survey (online) to all BCHO pediatric residents via an email list serve and also announced and handed out a paper version to them at their monthly residency meeting. The survey consisted of 13 questions, including demographics (age, ethnicity, race, gender, and year of residency), approximate numbers of patients with SCD seen clinically, comfort level in treating patients with SCD, perceived barriers to treatment of VOE with opioids, and attitudes toward patients with SCD (Supporting Information File). Survey questions about barriers to pain management were adapted from a survey about a range of chronic nonmalignant pain conditions. 10 Questions about attitudes toward patients with SCD were modified from questions previously developed for emergency department providers. 11 Participants' completion of the survey served as their consent to be in the research study.
Interviews
The residents' interview questions were adapted from the semistructured interview guides from the SCDIC needs assessment qualitative data collection. Interview topics included an introductory section on the residents' experience with SCD, primary and specialty care, hydroxyurea treatment, opioids and pain, and emergency department management (interview guide available upon request). For this study, interview topics including only experience level with SCD and pain management were coded and analyzed. Each interview for the five participating residents took about 30 to 45 minutes to complete and was conducted by an interviewer (AF) and a note taker (JK).
Audio recordings of each interview were transcribed by a professional transcription service, and the research team reviewed transcripts for accuracy prior to coding. The interview transcripts were imported into NVivo, a qualitative database (qsrinternational.com), and analyzed using thematic analysis. 13 We used successive coding passes to identify common themes and codes within the interview transcripts. Themes and codes were organized into a descriptive framework of the residents' ideas and experiences with opioids in treatment of sickle cell-related pain episodes (codebook available upon request). One researcher (AF) created the initial codebook, and themes were discussed with the senior researcher (MJT) to verify the validity of the codebook. Trained research assistants for the larger SCDIC study at BCHO coded the interviews. The research assistants met frequently with the senior researcher to ensure accuracy and consistency in coding and to resolve any discrepancies by consensus. The semistructured interviews were conducted with the prespecified plan to achieve saturation in codes and themes. 14 
Data analysis

RESULTS
Fifty-three of 88 (60.2%) residents completed the survey ( Table 1) .
The majority of the 53 participants were female (69.8%), aged 25 to 29 years (67.9%), and white (51.0%). All participants reported clinical experience with at least one patient with SCD during their medical career. Residents who reported clinical experience with 21 or more patients with SCD (45.3%) were categorized as "more experienced" residents, and those who reported having seen fewer than 21 patients with SCD were categorized as "less experienced."
More experienced residents (n = 24) reported feeling significantly more comfortable (responded "somewhat comfortable" or "very TA B L E 1 Characteristics of pediatric residents (n = 53) who participated in the survey 
TA B L E 2
Percentage of residents (n = 53) responding that each perceived barrier to treatment of VOE with opioids was a "moderate" or "complete" barrier
Less experienced (n = 29)
More experienced (n = 24) with SCD "are frustrating to take care of." Few residents reported that patients with SCD "over-report their pain" (11.3%), but few also expressed that patients with SCD "make me feel glad I went into medicine" (20.8%). Less experienced residents reported that they felt that patients with SCD are significantly easier to empathize with, compared with more experienced residents (69.0% vs. 41.7%; P < 0.05).
The five pediatric residents who were interviewed were primarily female (80%), white (60%), aged 30 to 34 years (60%), and categorized as "more experienced" residents (60%). The five narratives provided more in-depth understanding of our survey findings, and saturation was achieved with consistent codes and overarching themes generated (Supporting Information Table S1 ). The first theme was related to 
DISCUSSION
We describe, for the first time, perspectives of pediatric residents about barriers to pain management in SCD and their attitudes toward caring for patients with SCD, considering level of experience with caring for patients with SCD as a differentiating factor. We found that residents that we surveyed reported concerns about tolerance and dependence as major barriers to use of opioids in treatment of acute pain in SCD. Both tolerance (caused by adaptations in neuronal cells resulting in decreased pharmacological effects of a dose of a drug with repeated use) and physiological dependence (neuronal changes that require continued administration of a drug to prevent withdrawal symptoms) are legitimate concerns in the use of opioids. 15 These concerns are a result of limited pharmacologic options for SCD treatment and present yet another barrier to SCD care.
Less experienced residents were more likely to perceive addiction as a greater barrier to use of opioids in treatment of VOE than more experienced residents. Studies have shown that providers often assume much higher rates of addiction in the SCD community than actual rates show. 16 One study showed that medical residents and nurses perceived higher rates of opioid dependence in patients with SCD than physicians, although all groups' perceptions were still much higher than the actual rates of opioid dependence. 15 The term "diversion" is highly publicized within the context of the opioid crisis, 17 so we can speculate that this is indeed what the residents meant by their responses. Unfortunately, the interviews did not inform this particular question.
More than half of the less experienced residents identified lack of training as a barrier to the use of opioids in the treatment of VOE, a statement that was also articulated throughout the interviews. This highlights the need for targeted education early in residency training so that physicians develop the skills to safely and responsibly provide effective, evidence-based treatments for patients in pain. A variety of curricular approaches, including traditional didactic sessions, experiential case-based methods, patient panels, and digital toolkits, can be utilized by training programs to better equip residents to care
for patients with pain and attend to those who develop substance-use disorders. 7 Our qualitative analysis of the residents' perceptions supported the idea that residents of varying levels of experience felt that SCD should be considered as a separate category compared with other chronic nonmalignant pain requiring treatment with opioids.
Our analysis also captured how a vicious cycle can ensue wherein providers do not trust patients who question their ability to adequately manage SCD pain, and patients escalate in requests for more pain medications and/or increase monitoring of their health care providers. Our findings are consistent with previous reports from adults with SCD about their reluctance to seek needed care even when faced with potentially life-threatening complications or severe pain, due to negative interactions with providers. 18, 19 Lack of adherence among adults with SCD has also been associated with patients' negative interpersonal experiences and lower levels of trust in their providers. 20, 21 Certain negative views, such as "patients with SCD are frustrating to take care of," were prevalent among the pediatric residents. Qual- 
CONCLUSION
Both survey and interview data showed that pediatric residents per- 
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